{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:36:43Z","timestamp":1778690203229,"version":"3.51.4"},"reference-count":36,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Urticarial vasculitis (UV) is a rare form of small-vessel vasculitis characterized by persistent urticarial lesions and systemic manifestations. It differs from chronic spontaneous urticaria (CSU) both clinically and pathogenetically, often requiring systemic therapy. Despite its complexity, no standardized treatment algorithm exists. Methods: We conducted a retrospective, monocentric, observational study on 11 patients diagnosed with UV at the Dermatology Unit of Tor Vergata University Hospital (Rome) between 2014 and 2024. Demographic, clinical, serological, and therapeutic data were collected from medical records. The therapeutic response was assessed using the Urticaria Control Test (UCT) score. Results: The cohort comprised predominantly women (91%), with a mean age at diagnosis of 52.8 years. Autoimmune thyroiditis was the most frequent comorbidity (64%). Hypocomplementemia was detected in only one patient (9%), who also had systemic lupus erythematosus. Antihistamines, while usually prescribed, showed limited efficacy since none of the patients achieved complete remission with monotherapy. Systemic corticosteroids demonstrated rapid and effective control in acute phases. Omalizumab produced variable responses, with two patients achieving a high response (HR) and one reaching complete remission (CR). Methotrexate and cyclosporine yielded inconsistent outcomes. Due to the heterogeneity and limited sample size, statistical analyses were not performed. Conclusions: UV presents with diverse clinical profiles and therapeutic responses. No treatment proved universally efficacious, but corticosteroids and omalizumab were effective in an acute and maintenance phase, respectively. Our findings underscore the importance of individualized treatment plans and the need for further studies to define predictive biomarkers and therapeutic strategies in UV.<\/jats:p>","DOI":"10.3390\/jcm14134580","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T13:06:17Z","timestamp":1751288777000},"page":"4580","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Challenging Clinical Therapeutic Approach to Urticarial Vasculitis: A Case Series"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-3532","authenticated-orcid":false,"given":"Fabio","family":"Artosi","sequence":"first","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4025-7882","authenticated-orcid":false,"given":"Terenzio","family":"Cosio","sequence":"additional","affiliation":[{"name":"Department of Laboratory Sciences and Haematological Sciences, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Universit\u00e0 Cattolica Del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-9052","authenticated-orcid":false,"given":"Laura","family":"Diluvio","sequence":"additional","affiliation":[{"name":"Unit of Dermatology, Tor Vergata Policlinic Foundation, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1115-4270","authenticated-orcid":false,"given":"Gaetana","family":"Costanza","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filadelfo","family":"Coniglione","sequence":"additional","affiliation":[{"name":"Unit of Dermatology, Tor Vergata Policlinic Foundation, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4963-0663","authenticated-orcid":false,"given":"Maria","family":"Iacovantuono","sequence":"additional","affiliation":[{"name":"Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Matteini","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif \u00c7a\u011fla","family":"Kaya","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lambiase","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-6896","authenticated-orcid":false,"given":"Luca","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-6798","authenticated-orcid":false,"given":"Elena","family":"Campione","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijwd.2021.01.021","article-title":"Urticarial Vasculitis","volume":"7","author":"Gu","year":"2021","journal-title":"Int. J. Women\u2019s Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/ijd.IJD_227_18","article-title":"Normocomplementemic Urticarial Vasculitis: An Unusual Presentation","volume":"65","author":"Manappallil","year":"2020","journal-title":"Indian J. Dermatol."},{"key":"ref_3","first-page":"118","article-title":"Urticarial Vasculitis","volume":"6","author":"Aksoy","year":"2017","journal-title":"A Comprehensive Review of Urticaria and Angioedema"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e12305","DOI":"10.1002\/clt2.12305","article-title":"Differential Diagnosis between Urticarial Vasculitis and Chronic Spontaneous Urticaria: An International Delphi Survey","volume":"13","author":"Krause","year":"2023","journal-title":"Clin. Transl. Allergy"},{"key":"ref_5","first-page":"36","article-title":"Hypocomplementemic Urticarial Vasculitis Syndrome: A Case Report and Literature Review","volume":"5","author":"Buck","year":"2012","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaip.2018.05.006","article-title":"Mimickers of Urticaria: Urticarial Vasculitis and Autoinflammatory Diseases","volume":"6","author":"Davis","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ijd.15112","article-title":"Urticarial Vasculitis in a COVID-19 Recovered Patient","volume":"59","author":"Nasiri","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e15093","DOI":"10.1111\/dth.15093","article-title":"COVID-19 Vaccine-induced Urticarial Vasculitis","volume":"34","author":"Dash","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Matos, A.L., Figueiredo, C., and Gon\u00e7alo, M. (2022). Differential Diagnosis of Urticarial Lesions. Front. Allergy, 3.","DOI":"10.3389\/falgy.2022.808543"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaci.2018.09.007","article-title":"Treatment of Urticarial Vasculitis: A Systematic Review","volume":"143","author":"Kolkhir","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_11","first-page":"232470961348430","article-title":"Urticarial Vasculitis in a Teenage Girl","volume":"1","author":"McGuffin","year":"2013","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.iac.2004.01.007","article-title":"Urticarial Vasculitis and Hypocomplementemic Urticarial Vasculitis Syndrome","volume":"24","author":"Davis","year":"2004","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40257-024-00902-y","article-title":"Managing Urticarial Vasculitis: A Clinical Decision-Making Algorithm Based on Expert Consensus","volume":"26","author":"Rothermel","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3000605231189141","DOI":"10.1177\/03000605231189141","article-title":"A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Complicated by Eosinophilic Pneumonia: A Case Report and Review of the Literature","volume":"51","author":"Kaneko","year":"2023","journal-title":"J. Int. Med. Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cherrez-Ojeda, I., Vanegas, E., Felix, M., Mata, V.L., and Cherrez, A. (2018). Patient-Reported Outcomes in Urticarial Vasculitis Treated with Omalizumab: Case Report. BMC Dermatol., 18.","DOI":"10.1186\/s12895-018-0077-x"},{"key":"ref_16","first-page":"e60986","article-title":"Breaking out of the Hive: A Case Report on Hypocomplementemic Urticarial Vasculitis Syndrome","volume":"16","author":"Louis","year":"2024","journal-title":"Cureus"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ion, O., Obri\u0219c\u0103, B., Ismail, G., Sorohan, B., B\u0103l\u0103nic\u0103, S., Mircescu, G., and Sinescu, I. (2020). Kidney Involvement in Hypocomplementemic Urticarial Vasculitis Syndrome\u2014A Case-Based Review. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072131"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Vallianou, K., Skalioti, C., Liapis, G., Boletis, J.N., and Marinaki, S. (2020). A Case Report of Hypocomplementemic Urticarial Vasculitis Presenting with Membranoproliferative Glomerulonephritis. BMC Nephrol., 21.","DOI":"10.1186\/s12882-020-02001-6"},{"key":"ref_19","unstructured":"European Medicines Agency (2025, April 29). Xolair: EPAR\u2014Product information. Published 3 December 2024, Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/xolair#product-info."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13601-018-0222-y","article-title":"Normocomplementaemic Urticarial Vasculitis: Effective Treatment with Omalizumab","volume":"8","author":"Huebner","year":"2018","journal-title":"Clin. Transl. Allergy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2013.12.1076","article-title":"Development and Validation of the Urticaria Control Test: A Patient-Reported Outcome Instrument for Assessing Urticaria Control","volume":"133","author":"Weller","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA2LEN\/EDF\/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100107","DOI":"10.1016\/j.waojou.2020.100107","article-title":"Management of Urticarial Vasculitis: A Worldwide Physician Perspective","volume":"13","author":"Kolkhir","year":"2020","journal-title":"World Allergy Organ. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2500\/aap.2024.45.230092","article-title":"Total IgE as a Biomarker of Omalizumab Response in Chronic Spontaneous Urticaria: A Meta-Analysis","volume":"45","author":"Keller","year":"2024","journal-title":"Allergy Asthma Proc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/1744666X.2023.2268284","article-title":"Anifrolumab: First Biologic Approved in the EU Not Restricted to Patients with a High Degree of Disease Activity for the Treatment of Moderate to Severe Systemic Lupus Erythematosus","volume":"20","author":"Gensous","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2024.03.006","article-title":"Urticarial Vasculitis","volume":"44","author":"Wang","year":"2024","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13223-019-0339-0","article-title":"Autoimmune Thyroid Disease and Urticarial Vasculitis: Is There a Significant Association?","volume":"15","author":"Vanegas","year":"2019","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/JAA.S304099","article-title":"Real-World Experience on Omalizumab Treatment for Patients with Normocomplementemic Urticarial Vasculitis","volume":"14","author":"Liu","year":"2021","journal-title":"J. Asthma Allergy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/jama.2024.15568","article-title":"Chronic Spontaneous Urticaria","volume":"332","author":"Kolkhir","year":"2024","journal-title":"JAMA"},{"key":"ref_30","unstructured":"Baigrie, D., Bansal, P., Goyal, A., and Crane, J.S. (2025, February 15). Leukocytoclastic Vasculitis (Hypersensitivity Vasculitis), Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482159\/."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e15946","DOI":"10.1111\/dth.15946","article-title":"Omalizumab as a Corticosteroid-Sparing Agent in the Treatment of Bullous Pemphigoid","volume":"35","author":"Vassallo","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kobayashi, Y., Kanda, A., Van Bui, D., Yun, Y., Linh-Trung, N., Chu, H.H., Mitani, A., Suzuki, K., Asako, M., and Iwai, H. (2021). Omalizumab Restores Response to Corticosteroids in Patients with Eosinophilic Chronic Rhinosinusitis and Severe Asthma. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070787"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaci.2024.11.005","article-title":"Omalizumab Safety Concerns","volume":"155","author":"Pongdee","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5414\/CP204053","article-title":"Comparative Efficacy and Safety of Rituximab, Mycophenolate, Methotrexate, and Cyclophosphamide versus Azathioprine as Maintenance Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials","volume":"60","author":"Lee","year":"2022","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.jaip.2020.02.024","article-title":"Response of Omalizumab in Normocomplementemic Urticarial Vasculitis","volume":"8","author":"Chen","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.jaip.2023.05.033","article-title":"Association between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis","volume":"11","author":"Chuang","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/13\/4580\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:00:24Z","timestamp":1760032824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/13\/4580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":36,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["jcm14134580"],"URL":"https:\/\/doi.org\/10.3390\/jcm14134580","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}